CorPath® System Robotically Deployed Bioresorbable Vascular Scaffold During Live Broadcast of a Complex Coronary Intervention at 2015 C3 Conference

WALTHAM,  Corindus Vascular Robotics, a leading developer of precision vascular robotics, announced today that a complex percutaneous coronary intervention (PCI) was broadcast live to attendees of the 2015 Complex Cardiovascular Catheter Therapeutics Conference in Orlando, Florida. Interventional cardiologists from around the world watched Arif Al Nooryani, MD, perform the triple-vessel disease case robotically in real-time by deploying bioresorbable stents, wiring the lesion and placing the stents using the CorPath System.

During the procedure, Dr. Al Nooryani, Chief Executive Officer and Head of the Cardiology Department at Al Qassimi Hospital, Sharjah, United Arab Emirates, sat in the CorPath System's radiation-shielded interventional cockpit and did not need to wear a lead apron as he advanced the guidewires, balloons, and stents without being exposed to the hazards of x-ray radiation.

“This case showed how robotic technology is effective in the treatment of patients with complex disease, while protecting me from the occupational hazards of the cath lab,” said Dr. Al Nooryani. “The enhanced visualization and precision provided by the CorPath System enabled me to place the bioresorbable vascular scaffold with optimal results for my patient.”

Developed by Corindus Vascular Robotics, the CorPath System is the first FDA-cleared medical device to bring robotic-assisted precision to coronary interventional procedures. The CorPath System is currently indicated in the US only for percutaneous coronary interventions.

For more information about the CorPath System, visit www.corindus.com.

About Corindus Vascular Robotics, Inc.

Corindus Vascular Robotics, Inc. is a global technology leader in robotic-assisted percutaneous coronary interventions (PCIs). The Company’s FDA-cleared CorPath System is the first medical device that offers interventional cardiologists PCI procedure control from a radiation protective interventional cockpit. With the CorPath System, Corindus Vascular Robotics brings robotic precision to PCI procedures to help optimize clinical outcomes and minimize the costs associated with complications through improper stent placement with manual PCI procedures. Corindus Vascular Robotics stands behind its product with its unique $1,000 hospital credit "One Stent Program." For additional information, visit www.corindus.com, and follow @CorindusInc.

Source:  Business Wire